These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antitrypanosomal therapy for chronic Chagas' disease. Bestetti RB; Cardinalli-Neto A N Engl J Med; 2011 Sep; 365(13):1258-9; author reply 1259. PubMed ID: 21991909 [No Abstract] [Full Text] [Related]
3. Antitrypanosomal therapy for chronic Chagas' disease. Bern C N Engl J Med; 2011 Jun; 364(26):2527-34. PubMed ID: 21714649 [No Abstract] [Full Text] [Related]
4. Effects of immunosuppression and benzonidazole on Trypanosoma cruzi parasitism during experimental acute Chagas' disease. Okumura M; Mester M; Iriya K; Amato Neto V; Gama-Rodrigues J Transplant Proc; 1994 Jun; 26(3):1587-9. PubMed ID: 8030049 [No Abstract] [Full Text] [Related]
5. [Treatment of Chagas' disease]. Apt W Rev Med Chil; 1985 Feb; 113(2):162-6. PubMed ID: 3936147 [No Abstract] [Full Text] [Related]
6. Persistent infections in chronic Chagas' disease patients treated with anti-Trypanosoma cruzi nitroderivatives. Braga MS; Lauria-Pires L; Argañaraz ER; Nascimento RJ; Teixeira AR Rev Inst Med Trop Sao Paulo; 2000; 42(3):157-61. PubMed ID: 10887376 [TBL] [Abstract][Full Text] [Related]
7. An update on benznidazole for the treatment of patients with Chagas disease. Thakare R; Dasgupta A; Chopra S Drugs Today (Barc); 2018 Jan; 54(1):15-23. PubMed ID: 29569658 [TBL] [Abstract][Full Text] [Related]
8. Authors' reply: Vitamins in the treatment of chronic Chagas disease: adjuvant antiparasitary or antioxidant therapy? Andrade MC; Oliveira Mde F; Nagao-Dias AT; Coêlho IC; Cândido Dda S; Freitas EC; Coelho HL; Bezerra FS Rev Soc Bras Med Trop; 2014; 47(5):670-1. PubMed ID: 25467276 [No Abstract] [Full Text] [Related]
9. The role of benznidazole with cyanocobalamin and ascorbic acid in treating the chronic phase of Chagas disease. Ghobadifar MA; Kalani N; Gitiforouz M; Mosallanejad Z Rev Soc Bras Med Trop; 2014; 47(5):669. PubMed ID: 25467275 [No Abstract] [Full Text] [Related]
10. Comparative efficacies of TAK-187, a long-lasting ergosterol biosynthesis inhibitor, and benznidazole in preventing cardiac damage in a murine model of Chagas' disease. Corrales M; Cardozo R; Segura MA; Urbina JA; Basombrío MA Antimicrob Agents Chemother; 2005 Apr; 49(4):1556-60. PubMed ID: 15793138 [TBL] [Abstract][Full Text] [Related]
16. Chemotherapy of Chagas' disease: status and new developments. Cerecetto H; González M Curr Top Med Chem; 2002 Nov; 2(11):1187-213. PubMed ID: 12171581 [TBL] [Abstract][Full Text] [Related]
17. [Treatment of chronic Chagas' disease. Is the etiological treatment effective?]. Rassi A; Rassi Júnior A Arq Bras Cardiol; 1998 Oct; 71(4):643-6. PubMed ID: 10347944 [No Abstract] [Full Text] [Related]
18. The dog as model for chemotherapy of the Chagas' disease. Guedes PM; Veloso VM; Tafuri WL; Galvão LM; Carneiro CM; Lana Md; Chiari E; Ataide Soares K; Bahia MT Acta Trop; 2002 Oct; 84(1):9-17. PubMed ID: 12387906 [TBL] [Abstract][Full Text] [Related]
19. Should benznidazole be used in chronic Chagas' disease? Bestetti RB Lancet; 1997 Mar; 349(9052):653. PubMed ID: 9057760 [No Abstract] [Full Text] [Related]
20. Shift of excretory-secretory immunogens of Trypanosoma cruzi during human Chagas' disease. Jazín EE; Luquetti AO; Rassi A; Frasch AC Infect Immun; 1991 Jun; 59(6):2189-91. PubMed ID: 1903775 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]